Protein poly-ubiquitylation functions as a signal for protein degradation by the 26S proteasome. One mechanism of protein ubiquitylation involves three steps -activation of ubiquitin by an E1 enzyme, transfer to a carrier protein (E2) and ligation to the target in the presence of a ligase protein/complex (E3). The E2 and more especially the E3 proteins confer specificity for targeting ubiquitylation 1 .
Drosophila SINA (Seven in Absentia) and mammalian Siah (Seven in Absentia Homologue) are RING-containing proteins that function in protein degradation as parts of ubiquitin ligase (E3) components. In Drosophila, SINA has been shown to co-operate with Phyllopod (PHYL), Ebi and UBCD1 to facilitate the ubiquitylation and degradation of the transcriptional co-repressor Tramtrack 88 (TTK88) [2] [3] [4] [5] . In mammalian cells, a similar complex comprising Siah1, Siah-interacting protein (SIP), and the F-box protein Ebi bind to adenomatous polyposis coli (pAPC) to facilitate the ubiquitylation and degradation of β-catenin via a p53-dependent mechanism 6 . As well, Siah has been reported to bind directly to many proteins that are subsequently degraded, suggestive of a simpler E3 complex 7 .
Structurally, little is known about the E3 complexes formed with this family of proteins. It has been suggested that they form a novel complex similar to, but distinct from, the generic RING-containing E3 complexes characterized by the anaphase-promoting complex (APC) and the Skp1/Cul1/F-box protein (SCF) ligases. The Siah protein's dimeric nature alone suggests a variant complex, since none of the described complexes contain dimeric RING proteins.
Siah has recently received a great deal of attention because of its role in certain disease processes. For example, Siah regulates hypoxia-inducible factor-1alpha protein levels, itself a central regulator of the cellular response to hypoxia by hypoxia-induced interaction and Page 4 degradation of PHD prolyl hydroxylases 8 . Siah also interacts with synphilin-1 and α-synuclein and thus may play a role in Parkinson's Lewy body formation 9 .
Siah is a dimeric protein consisting of an N-terminal RING domain followed by two novel zinc finger motifs and a C-terminal substrate-binding domain (SBD). We have previously described the crystal structure of the murine Siah1a (missing the RING domain) to 2.6 Å resolution 10 . The structure revealed that Siah is a dimeric protein with each SBD adopting an eight-stranded β-sandwich fold. Each SBD is extended at the N-terminus by a tandem pair of zinc fingers. Analysis of the surface of the molecule suggested a number of regions that might interact with protein ligands. The dimer has two deep clefts located adjacent to the N-terminal zinc fingers of each monomer and a larger but shallower groove centred about the dimer interface. We hypothesised that the clefts might be filled by the RING domains that are N-terminal to the zinc fingers in the intact Siah molecule. The large shallow groove (~ 30 Å wide), constructed from a curved anti-parallel β-sheet that straddles the dimer interface, was considered as an alternative location for a protein-protein interaction region.
Reed and Ely 11 noted that the deep clefts have an overall electropositive potential whereas the shallow groove was strikingly electronegative. Mutagenesis of carboxylate residues (Glu161, Asp162, Glu226, Glu237) in the shallow groove of Siah resulting in loss of binding to the Siah-interacting protein, SIP, whereas mutations of basic residues in the deep clefts (Arg124, Arg214, Arg215, Arg231, Arg232) had no effect 12 . Interestingly, the binding of another Siah ligand, BAG1, was unaffected by mutations in either groove or cleft 12 . More recently we reported that many Siah-binding proteins contain a common binding motif that may act as a degradation signal or 'degron' 13 . However, attempts to computationally dock the consensus motif onto the Siah structure did not reveal the binding site for the degron (unpublished results).
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Here we report the crystal structure of the Siah bound to a degron motif-containing peptide that reveals a binding site for Siah-interacting proteins. This site is distinct from those previously hypothesised as protein interaction sites. We further show that mutation of Siah residues seen to interact with the degron abrogate binding to multiple partners, as well as inhibiting cellular proteasomal degradation of such proteins in co-transfection experiments.
RESULTS

Structure of the Siah bound to PHYL (107-130) peptide
We have determined the crystal structure of Siah (residues 92 to 282) in complex with the synthetic peptide encompassing residues 107-130 of Phyllopod (PHYL) (Fig. 1) , which includes the earlier identified common degron motif 13 . The structure of the complex was determined by molecular replacement using the previously published Siah (92-282) structure conformation to that of the uncomplexed structure due to the absence of a zinc ion. In the uncomplexed structure a zinc atom was located at the tip of the dimer interface and coordinated by Asp200, His202 from monomer and His202 of another monomer and His150 of symmetry-related molecule. We had previously suggested that this zinc site was unlikely to be physiologically relevant 10 .
The structure of the complex reveals the PHYL peptide-binding site located in a shallow surface groove formed by the beta-sandwich of the Siah SBD and β0 strand making up the connection between the second zinc finger domain and SBD ( Fig. 1) . Thus, there are two PHYL peptide binding sites on the Siah dimer separated by 45 Å. The peptide spans a length of 30 Å across the surface of the protein, from the concave surface formed by the antiparallel beta-sheet at one end of the dimer to the tip at the other end of the dimer (Fig. 1) .
Peptide-protein interactions further define the degron motif
Good electron density is observed for PHYL residues 114 to 124. The PHYL peptide adopts an extended conformation, packing against the β1 and β2 strands of the beta-sandwich of the Siah SBD (Figs. 1a,b) . The peptide makes several parallel beta-sheet interactions between its main chain and the main chain atoms of the β1-strand in Siah: the main chain carbonyl of 
Mutation of Siah residues that interact with PHYL (107-130) abrogates binding to PHYL in vitro
We used the crystal structure of the complex as a guide for mutagenesis studies in order to determine the relative importance of various interacting residues of Siah with its degron target (PHYL). We mutated Met180 to Lys to disturb the hydrophobic pocket harbouring Ala118
and Val120 of PHYL in the complex (Fig. 1c) . We also targeted residues located in β0 (Thr156 and Leu158) and β1 (Leu166, Thr168), as well as the residue Ala175 from the loop 172-177 to probe the role of PHYL residues 125 to 130 in the binding (Fig. 1b) . Leu158Lys, Leu158Asp, Thr168Arg, Leu166Lys, Ala175Glu, as well as the double mutations Thr156Glu/Leu158Asp and Leu166Lys/Thr168Arg, were prepared.
The effects of the mutations were tested in in vitro pull down assays as described in the Methods. The results are presented in Figure 3 . Met180Lys almost completely abolishes binding of the target by Siah, underlying the importance of the hydrophobic interaction observed in the crystal structure and suggesting that it is a key recognition/specificity point.
The mutations in strand β0 had more pronounced effects than the mutations in β1. The side chains of the residues from strand β0 point into the PHYL binding groove of Siah. Ala175Glu has slightly increased PHYL binding, which may be due to potential additional hydrogen bonding contacts provided by the Glu side chain towards PHYL, particularly considering that the PHYL residue 125 that interacts with Siah at that position is an arginine residue.
Siah binding mutants fail to facilitate degradation of substrates
To examine whether the identified binding site is also responsible for the binding induced degradation of Siah targets in mammalian cells, we examined the Siah substrate TIEG-1. The transcriptional repressor, TIEG-1, is a mammalian degradation target for Siah 14 that also possesses the consensus degron motif 13 . To investigate the relevance of the peptide-binding site to substrate protein degradation, co-transfection experiments were performed in mammalian HEK293T cells. Siah was shown to increase the rate of degradation of TIEG-1 when co-transfected (Fig. 3) . Degradation was shown to be proteasome-dependent by the addition of the proteasome inhibitor MG132 (Fig. 3b) . When mutant Siah was introduced in these experiments, TIEG-1 degradation was affected to varying degrees mirroring the pull down assay results (cf. Figs. 2 and 3a) . In particular, mutations in β1-strand of Siah involving residues Leu166 and Thr168 that only partly disrupted PHYL binding (Fig. 2) did not rescue TIEG-1 degradation (Fig. 3a) . Siah mutants at Met180 and Leu158, which bound PHYL peptide poorly (Fig. 2) , failed to degrade TIEG-1 (Fig. 3a) . The mutation of Ala175 to glutamate apparently promoted the binding of PHYL to Siah (see above and showed that it was no longer degraded in the presence of co-transfected Siah (Fig. 3c) .
DISCUSSION
The structure of the complex between Siah (residues 92 to 282) and PHYL (residues 107-130) reveals that the degron recognition site is located in a shallow surface groove formed by the beta-sandwich of the Siah SBD and a β-strand that connects the second zinc finger domain to SBD. This site has not previously been identified as a possible protein interaction site. There Page 10 are two PHYL peptide-binding sites per dimer with each peptide spanning a length of 30 Å across the surface of the protein (Fig. 1) . The structure provides a molecular basis for understanding the importance of the previously published degron motif, Pro-X-Ala-X-Val-XPro 13 . Pro116, Ala118, Val120 and Pro122 are all in direct contact with Siah in the complex structure. Ala118 and Val120 embed their side chains into the hydrophobic core of the betasandwich where the binding pockets are too small to accommodate larger side chains. Pro116
and Pro122 ensure the extended conformation of the motif for optimal presentation of the main chain carbonyls and amides of PHYL to the backbone atoms of the β strands of Siah.
Pro122 also packs against the conserved Siah residue Trp178.
In the Siah:PHYL complex crystal structure we only observe electron density corresponding to 114-124 of PHYL even though the peptide used in the crystallization included residues 107 to 130. Thus residues 108-113 and 125-130 are flexible and could not be modelled. Non-consensus residues that do interact with Siah include Arg115 and Thr123.
Arg115 interacts with an acidic patch on Siah's concave surface involving residue Asp162 that was previously implicated in substrate recognition 12 and Asn276. Modelling suggests that Arg111 or Lys113 could form a salt bridge to either Glu161 or Glu226 (although the peptides from the two binding sites could clash in this case). Arg125 on the C-terminal end of PHYL could form a salt bridge with Glu194 (a strictly conserved residue in Siah) or to Glu197.
However, the latter is unlikely to be a significant interaction as it would be expected to have Prior to crystallization, the protein was desalted on a NAP-25 column using a buffer consisting of 25 mM Tris pH 8.0, 0.2 mM DTT and concentrated using an Amicon concentrator to 10 mg/ml.
Crystallization of Siah-PHYL complex. Siah was mixed with a synthetic Phyllopod (PHYL) peptide 107-130 (Auspep, synthesized with free amino terminus and C-terminal amide, at >95% purity) at a 1:1 ratio and then incubated for 2 hours at room temperature.
Crystallization was performed at 295 K using the hanging-drop vapor-diffusion technique.
Very thin plate shaped crystals (2 mm x 2 mm x 0.03 mm) grew within a week when 2 µl (v/v) glycerol was used as a cryo-protectant. Data were processed using the HKL package 15 .
The diffraction data statistics are shown in Table 1 (Table 1) with 77.6% residues in the most favored region of the Ramachandran plot, only 3 residues in the generously allowed regions and none in the disallowed regions. Other stereochemical parameters such as side chain chi angle values, peptide bond planarity, alpha-carbon tetrahedral distortions and non-bonded interactions are all better than or within the allowed ranges defined by PROCHECK 17 .
Mutagenesis experiments. Siah and TIEG-1 mutants were made using the Stratagene QuikChange Mutagenesis Kit. The mutations were confirmed by restriction enzyme digest and DNA sequencing. The Siah mutants were expressed using the protocol for wild-type Siah and purified using His-Bind Quick 300 Cartridges (Novagen). The His-tag was retained for use in pull-down assays. The mutagenic oligo pairs for Siah are as follows: 
